Heart Genomics, LLC is a biotechnology company based in Miami Beach, FL, specializing in the development and commercialization of non-invasive, genomic-based diagnostic tests for patients with heart disease or heart failure. Their personalized tests provide individualized information to patients and their physicians, enabling them to make improved treatment decisions.
With a focus on genomic analysis of heart tissue or blood samples, Heart Genomics is at the forefront of the rapidly growing molecular diagnostics market, offering innovative solutions that enhance the understanding and management of heart conditions.
Generated from the website